Sequoia Capital Israel

Normunity is a biotechnology company that develops precision immuno‑oncology medicines, termed immune normalizers, designed to restore the body’s natural immune response against cancer. Leveraging a partnership with Dr. Lieping Chen’s laboratory at Yale School of Medicine, the company focuses on newly discovered mechanisms of immune disruption, such as the exclusion of T‑cells from immune‑sensitive tumors and other barriers to normal immune function. Its pipeline includes programs targeting these mechanisms to enable clinicians to treat cancer by reactivating the patient’s own immunity. Normunity operates from offices in Boston, Massachusetts, and West Haven, Connecticut.

Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Sigmoid is a Data Solutions company offering best-in-class services in Data Engineering and Data Science. With over 110 team members driven by a passion for unraveling data complexities, Sigmoid generates actionable insights and translates them into successful business strategies. The company leverages expertise in Open Source and Cloud Technologies to develop innovative frameworks tailored to specific client needs, positively influencing the performance of Fortune 1000 clients worldwide.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Airmeet operates an immersive virtual events platform for event organizers, marketers, community builders, and enterprises. Its scalable platform supports various event formats such as fairs, expos, meetups, workshops, summits, and town halls.

Personetics Technologies Ltd. is a provider of customer interaction technology designed specifically for the financial services sector. Founded in 2010 and headquartered in White Plains, New York, the company also has a research and development center in Nazareth, Israel, and additional offices in Tel Aviv, Israel, and Singapore. Personetics offers a range of solutions, including the Personetics Digital Banker, which facilitates customer-centric processes across various digital channels, and Personetics Anywhere, which enables personalized assistance through messaging platforms. The company’s Self-Driving Finance platform engages retail and small business customers by providing tailored guidance in financial management. By leveraging real-time analytics and a library of banking-specific predictions, Personetics empowers financial institutions to enhance customer experiences, convert passive users into active participants, and streamline operations.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.

dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.

Airmeet operates an immersive virtual events platform for event organizers, marketers, community builders, and enterprises. Its scalable platform supports various event formats such as fairs, expos, meetups, workshops, summits, and town halls.

Simcha Therapeutics is a biopharmaceutical company focused on developing engineered cytokine immunotherapy for cancer treatment. Founded in 2018 and headquartered in New Haven, Connecticut, the company utilizes directed evolution to create novel cytokines that enhance the immune system's ability to combat diseases. Its lead program, ST-067, is a designer IL-18 cytokine that has demonstrated significant antitumor effects in animal models, both as a standalone treatment and in combination with anti-PD-1 checkpoint inhibitors. This innovative approach aims to provide patients with more effective immunotherapies, thereby improving their ability to fight cancer.

RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Silk is a technology company that focuses on enhancing AI innovation by providing real-time access to production data in the cloud. It integrates high-performance cloud storage into AI workflows, allowing organizations to improve innovation while ensuring performance, reliability, and control over their enterprise data. Silk's agile data delivery system eliminates the need to copy production data, thereby increasing flexibility and enabling the utilization of production data for Generative AI applications. The company holds over 20 technology patents, which support its mission to help customers maximize the advantages of the public cloud with speed and ease. Silk is headquartered near Boston, Massachusetts.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Skyline AI Ltd is a technology company specializing in artificial intelligence applications for the commercial real estate sector. Founded in 2017 and headquartered in New York, with an additional office in Tel Aviv, the company has developed a sophisticated platform that streamlines and digitizes the real estate investment process. This platform utilizes live data to forecast future rent and disposition prices, identify market trends, and locate properties with optimal risk-reward ratios. By leveraging both static and time series data from various sources, Skyline AI enhances due diligence, assesses risk and yield, and provides ongoing management and monitoring for investment opportunities. The company's advanced technology aims to simplify legal, tax, and financial aspects for both domestic and international investors, granting them access to institutional-grade commercial real estate opportunities.

Founded in 2018, Brii Biosciences is a biotechnology company dedicated to researching, developing, and commercializing medicines for chronic illnesses, with a primary focus on infectious diseases. Headquartered in Durham, North Carolina, the company operates additional offices in Shanghai and Beijing, China; and San Francisco, California.

Skyline AI Ltd is a technology company specializing in artificial intelligence applications for the commercial real estate sector. Founded in 2017 and headquartered in New York, with an additional office in Tel Aviv, the company has developed a sophisticated platform that streamlines and digitizes the real estate investment process. This platform utilizes live data to forecast future rent and disposition prices, identify market trends, and locate properties with optimal risk-reward ratios. By leveraging both static and time series data from various sources, Skyline AI enhances due diligence, assesses risk and yield, and provides ongoing management and monitoring for investment opportunities. The company's advanced technology aims to simplify legal, tax, and financial aspects for both domestic and international investors, granting them access to institutional-grade commercial real estate opportunities.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Moderna is a biotechnology company focused on messenger RNA therapeutics and vaccines. It develops mRNA-based medicines that instruct cells to produce therapeutic proteins or antibodies in vivo, targeting infectious diseases, oncology, cardiovascular diseases, and rare genetic disorders. Founded in 2010 and headquartered in Cambridge, Massachusetts, the company has built a broad pipeline with multiple development candidates across several modalities and a track record highlighted by a COVID-19 vaccine authorized in the United States. Moderna collaborates with major pharmaceutical and research partners, including AstraZeneca, Merck, Vertex, and Alexion, as well as academic institutions such as Harvard University and Karolinska Institutet. It maintains manufacturing collaborations with Lonza for mRNA production and Catalent for fill-finish, and engages with public sector and philanthropic supporters such as BARDA, DARPA, and the Gates Foundation. As of 2025, the company continued expanding its mRNA development program across infectious disease, oncology, cardiovascular, and rare genetic diseases.

XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.

Lemonade, Inc. is an innovative insurance company that provides a range of insurance products in the United States and Europe, including homeowners, renters, and landlord insurance. Founded in 2015 and headquartered in New York, the company utilizes artificial intelligence and behavioral economics to streamline the insurance process, eliminating traditional brokers and paperwork. By employing advanced technology, Lemonade offers instant service and sets competitive rates for its policies. The company also acts as an agent for other insurance providers, further expanding its offerings. With a commitment to social good, Lemonade aims to transform the insurance industry by prioritizing transparency and efficiency.

Capitolis develops an online SaaS platform that connects global banks with institutional investors. Its technology enhances the efficiency of capital markets by facilitating seamless transactions, improving access to diversified capital, and optimizing risk management.

Ucommune is a flexible office space provider and manager headquartered in Beijing. It offers fully serviced, furnished workspaces with long-term, on-demand, and short-term leasing for freelancers, startups, small and medium-sized enterprises, and corporations. The company operates in China and internationally, including Singapore, New York City, San Francisco, and London, leveraging a member community and a platform to deliver workspace membership as well as marketing, branding, and related services.

Lemonade, Inc. is an innovative insurance company that provides a range of insurance products in the United States and Europe, including homeowners, renters, and landlord insurance. Founded in 2015 and headquartered in New York, the company utilizes artificial intelligence and behavioral economics to streamline the insurance process, eliminating traditional brokers and paperwork. By employing advanced technology, Lemonade offers instant service and sets competitive rates for its policies. The company also acts as an agent for other insurance providers, further expanding its offerings. With a commitment to social good, Lemonade aims to transform the insurance industry by prioritizing transparency and efficiency.

Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

Eko is a media and technology company pioneering a new medium in which stories told in live action video are shaped by viewers as they unfold. The company provides a platform for the creation and delivery of interactive video entertainment and partners with media companies, independent creators, and top brands to create experiences for highly-engaged, digitally native audiences. The company's serialized shows are distributed through eko.com, affiliate partners, and social networks; available on desktop, mobile, connected devices, and VR. Eko Studio, which includes the company's authoring tools, is also home to a large and growing community of creators who are crafting their own interactive experiences with Eko's medium. Eko provides top-quality interactive entertainment and also offers unique opportunities for brands to connect with highly-engaged audiences. Eko investors include Walmart, Innovation Endeavors, Intel Capital, Marker, MGM, NEA, Samsung, Sequoia Capital, Sony Pictures Entertainment, Warner Music Group, and WPP. The company is based in New York with an office in Tel Aviv.

Lemonade, Inc. is an innovative insurance company that provides a range of insurance products in the United States and Europe, including homeowners, renters, and landlord insurance. Founded in 2015 and headquartered in New York, the company utilizes artificial intelligence and behavioral economics to streamline the insurance process, eliminating traditional brokers and paperwork. By employing advanced technology, Lemonade offers instant service and sets competitive rates for its policies. The company also acts as an agent for other insurance providers, further expanding its offerings. With a commitment to social good, Lemonade aims to transform the insurance industry by prioritizing transparency and efficiency.

Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.

Ucommune is a flexible office space provider and manager headquartered in Beijing. It offers fully serviced, furnished workspaces with long-term, on-demand, and short-term leasing for freelancers, startups, small and medium-sized enterprises, and corporations. The company operates in China and internationally, including Singapore, New York City, San Francisco, and London, leveraging a member community and a platform to deliver workspace membership as well as marketing, branding, and related services.

Whale Imaging Inc., established in 1998, is a Massachusetts-based manufacturer of medical devices specializing in surgical imaging systems and ultrasound equipment. The company's product portfolio includes G-Arm Products like the G-Arm B6 Duo and G-Arm GXi 2, as well as portable ultrasound systems such as the Lambda P9 and Sigma P5. In addition to manufacturing, Whale Imaging offers training services, preventative maintenance, and customer support for its products. The company's headquarters are in Waltham, Massachusetts, with research and development facilities located in Boston.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

Near Pte. Ltd., also known as AdNear, operates a location-based intelligence platform that delivers real-time insights about places, people, and products. Founded in 2012 and headquartered in Singapore, the company specializes in data-driven solutions that help brands and publishers engage and analyze audiences. Its offerings include Allspark, a mobile-first audience cloud solution, and Carbon, which analyzes real-world consumer behavior across significant locations. Near's platform processes data from approximately 1.6 billion unique user IDs and 70 million points of interest across over 44 countries, enabling clients to better understand consumer behaviors and preferences. The company serves a diverse range of industries, including retail, technology, travel, telecommunications, and financial services, with additional offices in major global cities such as San Francisco, New York, London, Bengaluru, Tokyo, and Sydney.

Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.

Kontera Technologies is a San Francisco-based company established in 2003 that specializes in Internet-based big data marketing solutions for marketers and publishers. The company offers a content activation platform that analyzes and correlates over 400 million daily conversations and content views in real-time, utilizing data from 15,000 exclusive publishers and many top-ranking websites. This platform dynamically activates brands' owned content, advertising, and organic content to enhance marketing effectiveness across display, mobile, and social environments. Kontera's services include an in-text advertising solution, ContentLink, which identifies contextually relevant keywords on publishers' web pages and matches them with appropriate advertisements. The company reaches more than 170 million consumers monthly and serves notable advertisers such as Chrysler, GM, Kraft, P&G, and Microsoft. Kontera is supported by several venture capital firms and maintains offices in multiple cities, including Atlanta, Boston, Chicago, Detroit, Los Angeles, New York, London, and Tel Aviv.

Personetics Technologies Ltd. is a provider of customer interaction technology designed specifically for the financial services sector. Founded in 2010 and headquartered in White Plains, New York, the company also has a research and development center in Nazareth, Israel, and additional offices in Tel Aviv, Israel, and Singapore. Personetics offers a range of solutions, including the Personetics Digital Banker, which facilitates customer-centric processes across various digital channels, and Personetics Anywhere, which enables personalized assistance through messaging platforms. The company’s Self-Driving Finance platform engages retail and small business customers by providing tailored guidance in financial management. By leveraging real-time analytics and a library of banking-specific predictions, Personetics empowers financial institutions to enhance customer experiences, convert passive users into active participants, and streamline operations.

Eko is a media and technology company pioneering a new medium in which stories told in live action video are shaped by viewers as they unfold. The company provides a platform for the creation and delivery of interactive video entertainment and partners with media companies, independent creators, and top brands to create experiences for highly-engaged, digitally native audiences. The company's serialized shows are distributed through eko.com, affiliate partners, and social networks; available on desktop, mobile, connected devices, and VR. Eko Studio, which includes the company's authoring tools, is also home to a large and growing community of creators who are crafting their own interactive experiences with Eko's medium. Eko provides top-quality interactive entertainment and also offers unique opportunities for brands to connect with highly-engaged audiences. Eko investors include Walmart, Innovation Endeavors, Intel Capital, Marker, MGM, NEA, Samsung, Sequoia Capital, Sony Pictures Entertainment, Warner Music Group, and WPP. The company is based in New York with an office in Tel Aviv.

Scodix Ltd. manufactures and markets advanced digital print enhancement presses tailored for the graphic arts and packaging industries. Founded in 2007 and headquartered in Rosh Ha'ayin, Israel, with an additional office in Saddle Brook, New Jersey, Scodix provides a range of equipment that enables commercial printers and converters to add unique embellishments such as gloss, metallic finishes, and embossing to various products, including marketing materials, greeting cards, business cards, and packaging for personal care and cosmetics. The company also offers web-to-print solutions for online ordering and serves print service providers, designers, and brand owners. Its product portfolio includes the Scodix Ultra Series, Scodix Foil, and Scodix SENSE™ experience, which enhances differentiation in printed products. Scodix supports its offerings with imaging software solutions, training courses, and a knowledge center, reaching customers through a global network of distributors and strategic alliances with key industry players.

Near Pte. Ltd., also known as AdNear, operates a location-based intelligence platform that delivers real-time insights about places, people, and products. Founded in 2012 and headquartered in Singapore, the company specializes in data-driven solutions that help brands and publishers engage and analyze audiences. Its offerings include Allspark, a mobile-first audience cloud solution, and Carbon, which analyzes real-world consumer behavior across significant locations. Near's platform processes data from approximately 1.6 billion unique user IDs and 70 million points of interest across over 44 countries, enabling clients to better understand consumer behaviors and preferences. The company serves a diverse range of industries, including retail, technology, travel, telecommunications, and financial services, with additional offices in major global cities such as San Francisco, New York, London, Bengaluru, Tokyo, and Sydney.

Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.

Founded in 2006, UnitedLex is a global provider of technology-powered legal and business solutions. It offers services such as litigation support, electronic data discovery, document review, contract management, intellectual property solutions, compliance services, and law department consultancy to corporate clients and law firms worldwide.

Personetics Technologies Ltd. is a provider of customer interaction technology designed specifically for the financial services sector. Founded in 2010 and headquartered in White Plains, New York, the company also has a research and development center in Nazareth, Israel, and additional offices in Tel Aviv, Israel, and Singapore. Personetics offers a range of solutions, including the Personetics Digital Banker, which facilitates customer-centric processes across various digital channels, and Personetics Anywhere, which enables personalized assistance through messaging platforms. The company’s Self-Driving Finance platform engages retail and small business customers by providing tailored guidance in financial management. By leveraging real-time analytics and a library of banking-specific predictions, Personetics empowers financial institutions to enhance customer experiences, convert passive users into active participants, and streamline operations.

Eko is a media and technology company pioneering a new medium in which stories told in live action video are shaped by viewers as they unfold. The company provides a platform for the creation and delivery of interactive video entertainment and partners with media companies, independent creators, and top brands to create experiences for highly-engaged, digitally native audiences. The company's serialized shows are distributed through eko.com, affiliate partners, and social networks; available on desktop, mobile, connected devices, and VR. Eko Studio, which includes the company's authoring tools, is also home to a large and growing community of creators who are crafting their own interactive experiences with Eko's medium. Eko provides top-quality interactive entertainment and also offers unique opportunities for brands to connect with highly-engaged audiences. Eko investors include Walmart, Innovation Endeavors, Intel Capital, Marker, MGM, NEA, Samsung, Sequoia Capital, Sony Pictures Entertainment, Warner Music Group, and WPP. The company is based in New York with an office in Tel Aviv.

Scodix Ltd. manufactures and markets advanced digital print enhancement presses tailored for the graphic arts and packaging industries. Founded in 2007 and headquartered in Rosh Ha'ayin, Israel, with an additional office in Saddle Brook, New Jersey, Scodix provides a range of equipment that enables commercial printers and converters to add unique embellishments such as gloss, metallic finishes, and embossing to various products, including marketing materials, greeting cards, business cards, and packaging for personal care and cosmetics. The company also offers web-to-print solutions for online ordering and serves print service providers, designers, and brand owners. Its product portfolio includes the Scodix Ultra Series, Scodix Foil, and Scodix SENSE™ experience, which enhances differentiation in printed products. Scodix supports its offerings with imaging software solutions, training courses, and a knowledge center, reaching customers through a global network of distributors and strategic alliances with key industry players.

Kontera Technologies is a San Francisco-based company established in 2003 that specializes in Internet-based big data marketing solutions for marketers and publishers. The company offers a content activation platform that analyzes and correlates over 400 million daily conversations and content views in real-time, utilizing data from 15,000 exclusive publishers and many top-ranking websites. This platform dynamically activates brands' owned content, advertising, and organic content to enhance marketing effectiveness across display, mobile, and social environments. Kontera's services include an in-text advertising solution, ContentLink, which identifies contextually relevant keywords on publishers' web pages and matches them with appropriate advertisements. The company reaches more than 170 million consumers monthly and serves notable advertisers such as Chrysler, GM, Kraft, P&G, and Microsoft. Kontera is supported by several venture capital firms and maintains offices in multiple cities, including Atlanta, Boston, Chicago, Detroit, Los Angeles, New York, London, and Tel Aviv.

Kontera Technologies is a San Francisco-based company established in 2003 that specializes in Internet-based big data marketing solutions for marketers and publishers. The company offers a content activation platform that analyzes and correlates over 400 million daily conversations and content views in real-time, utilizing data from 15,000 exclusive publishers and many top-ranking websites. This platform dynamically activates brands' owned content, advertising, and organic content to enhance marketing effectiveness across display, mobile, and social environments. Kontera's services include an in-text advertising solution, ContentLink, which identifies contextually relevant keywords on publishers' web pages and matches them with appropriate advertisements. The company reaches more than 170 million consumers monthly and serves notable advertisers such as Chrysler, GM, Kraft, P&G, and Microsoft. Kontera is supported by several venture capital firms and maintains offices in multiple cities, including Atlanta, Boston, Chicago, Detroit, Los Angeles, New York, London, and Tel Aviv.

Kontera Technologies is a San Francisco-based company established in 2003 that specializes in Internet-based big data marketing solutions for marketers and publishers. The company offers a content activation platform that analyzes and correlates over 400 million daily conversations and content views in real-time, utilizing data from 15,000 exclusive publishers and many top-ranking websites. This platform dynamically activates brands' owned content, advertising, and organic content to enhance marketing effectiveness across display, mobile, and social environments. Kontera's services include an in-text advertising solution, ContentLink, which identifies contextually relevant keywords on publishers' web pages and matches them with appropriate advertisements. The company reaches more than 170 million consumers monthly and serves notable advertisers such as Chrysler, GM, Kraft, P&G, and Microsoft. Kontera is supported by several venture capital firms and maintains offices in multiple cities, including Atlanta, Boston, Chicago, Detroit, Los Angeles, New York, London, and Tel Aviv.

SintecMedia Ltd. engages in the design and implementation of management systems for the broadcast, cable, and satellite industries. It offers OnAir, a broadcast management system, which manages airtime sales, traffic, programming, and promotion campaigns. The company also provides system configuration, data migration, training, integration, support and maintenance, and project management services. Its product is used in various networks in North America, Europe, and Asia. The company was founded in 2000 and is based in New York, New York with additional offices in Denver, Toronto, London, and Jerusalem. SintecMedia Ltd. is a former subsidiary of Sintec Advanced Technologies, Ltd.

Traiana, Inc. specializes in pre-trade risk management and post-trade processing solutions for various financial market participants, including banks, broker-dealers, buy-side firms, and trading platforms globally. Founded in 2000 and headquartered in New York, Traiana operates a comprehensive network that facilitates global market connectivity for trades in foreign exchange, equities, and derivatives. Its product offerings include Harmony, a network for processing trades; CCP Connect, which provides trade registration and regulatory compliance; ClientLink, an automated client servicing solution; and CreditLink, which ensures pre-trade and post-trade certainty regarding clearing risk. Additionally, Traiana offers solutions for margin monitoring, post-trade processing for prime brokers, trade reporting, and services tailored to support integration and training. With a robust infrastructure in place, Traiana enhances operational efficiency and risk management for financial institutions worldwide. It operates as a subsidiary of CME Group and has offices in major financial hubs, including Chicago, Hong Kong, London, Singapore, Tel Aviv, and Tokyo.

Kontera Technologies is a San Francisco-based company established in 2003 that specializes in Internet-based big data marketing solutions for marketers and publishers. The company offers a content activation platform that analyzes and correlates over 400 million daily conversations and content views in real-time, utilizing data from 15,000 exclusive publishers and many top-ranking websites. This platform dynamically activates brands' owned content, advertising, and organic content to enhance marketing effectiveness across display, mobile, and social environments. Kontera's services include an in-text advertising solution, ContentLink, which identifies contextually relevant keywords on publishers' web pages and matches them with appropriate advertisements. The company reaches more than 170 million consumers monthly and serves notable advertisers such as Chrysler, GM, Kraft, P&G, and Microsoft. Kontera is supported by several venture capital firms and maintains offices in multiple cities, including Atlanta, Boston, Chicago, Detroit, Los Angeles, New York, London, and Tel Aviv.

marketRx, founded in 2000, is a provider of an analytics software platform tailored for pharmaceutical and biotechnology companies. Based out of Bridgewater, New Jersey, with additional offices in Doylestown, Pennsylvania, Scottsdale, Arizona, Berkshire, UK, and India, the company has grown to over 350 employees. marketRx's platform aims to enhance the effectiveness of sales and marketing strategies for its clients, which include top pharmaceutical companies and a diverse range of biotechnology and medical device firms. The company's global presence allows it to support collaborative projects across various regions, including Europe and Asia Pacific.

Traiana, Inc. specializes in pre-trade risk management and post-trade processing solutions for various financial market participants, including banks, broker-dealers, buy-side firms, and trading platforms globally. Founded in 2000 and headquartered in New York, Traiana operates a comprehensive network that facilitates global market connectivity for trades in foreign exchange, equities, and derivatives. Its product offerings include Harmony, a network for processing trades; CCP Connect, which provides trade registration and regulatory compliance; ClientLink, an automated client servicing solution; and CreditLink, which ensures pre-trade and post-trade certainty regarding clearing risk. Additionally, Traiana offers solutions for margin monitoring, post-trade processing for prime brokers, trade reporting, and services tailored to support integration and training. With a robust infrastructure in place, Traiana enhances operational efficiency and risk management for financial institutions worldwide. It operates as a subsidiary of CME Group and has offices in major financial hubs, including Chicago, Hong Kong, London, Singapore, Tel Aviv, and Tokyo.